The Breast
Volume 19, Issue 1 , Pages 23-27 , February 2010

Translational breast cancer research: Recent advances through the lens of experimental radiotherapy

Received 21 July 2009 ,Revised 15 October 2009 ,Accepted 17 October 2009.

References 

  1. Matthews LA, Crea F, Farrar WL. Epigenetic gene regulation in stem cells and correlation to cancer. Differentiation. 2009;78:1–17
  2. Woodward WA, Bisrat Debeb L, Hall C, Xu W, Reuben J, Gao H, et al. Characterizing breast cancer stem cells survival signaling from primary human breast tumour cells. Radiother Oncol. 2009;90(Suppl.3):S26;[abstract 70]
  3. Alexe G, Dalgin GS, Scanfeld D, Tamayo P, Mesirov JP, Ganesan S, et al. Breast cancer stratification from analysis of micro-array data of micro-dissected specimens. Genome Infor. 2007;18:130–140
  4. Kreike B, Halfwerk H, Armstrong N, Bult P, Foekens JA, Veltkamp SC, et al. Local recurrence after breast-conserving therapy in relation to gene expression patters in a large series of patients. Clin Cancer Res. 2009;15:4181–4190
  5. Goyal S, Parikh RR, Green C, Schiff D, Moran MS, Yang Q, et al. Clinicopathologic significance of excision repair cross-complementation 1 expression in patients treated with breast-conserving surgery and radiation therapy. J Radiat Oncol Biol Phys. 2009;may 21 (ahead)
  6. Liu W, Ip Mm, Podgorsak MB, Das GM. Disruption of estrogen receptor alpha-p53 interaction in breast tumours: a novel mechanism underlying the anti-tumour effect of radiation therapy. Breast Cancer Res Treat. 2009;115:43–50
  7. Powell SN. Recognizing the role of homologous recombination in DNA double strand break repair in human cancer. Radiother Oncol. 2009;90(Suppl.3):S22;[abstract 58]
  8. Monnier Y, Farmer P, Bieler G, Imaizumi N, Kuonen F, Sengstag T, et al. The tumour microenvironment: contribution to tumour progression and therapeutic implications. Radiother Oncol. 2009;90(Suppl.3):[abstract 38]
  9. Klopp AH, Watson K, Meyn R, Munshi A, Andreef M, Marini F. Mesenchymal stromal cells engraft in preferentially in irradiated tumours and impact tumour response to radiation. Radiother Oncol. 2009;90(Suppl.3):S55;[abstract 134]
  10. Dikomey E, Borgmann K, Raabe A, Reuther S. Genetic determination of late tissue reaction after radiation therapy. Radiother Oncol. 2009;90(Suppl.3):S31;[abstract 81]
  11. Marangoni E, Vincent-Salomon A, Auger N, Degeorges A, Assayag F, de Cremoux P, et al. A new model of patient-derived breast cancer xenografts for preclinical assays. Clin Cancer Res. 2007;13:3989–3998
  12. Poupon MF, Lecomte N, Durand L, Fontaine JJ, Chateau-Joubert S, DePinieux G, et al. Identification and characterization of CD44 positive cells in tumour recurrence after chemotherapy-induced remission in basal-like human breast cancer xenografts. Radiother Oncol. 2009;90(Suppl.3):S119;[abstract 266]
  13. Jonkers J, Berns A. Conditional mouse models of sporadic cancer. Nat Rev Cancer. 2002;2:251–265
  14. Jonkers J, Meuwissen R, van der Gulden H, Peterse H, van der Valk M, Berns A. Synergistic tumour suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer. Nat Genet. 2001;29:418–425
  15. Rottenberg S, Jaspers JE, Kersbergen A, van der Burg E, Nygren AO, Zander SA, et al. High sensitivity of BRCA1-deficient mammary tumours to the PARP inhibitor AZD2281 alone and in combination with platinum drugs. Proc Natl Acad Sci USA. 2008;105:17079–17084
  16. Jonkers J. Acquired resistance to platinum drugs: what animal model data teach us. Radiother Oncol. 2009;90(Suppl.3):S32;[abstract 86]
  17. Zerp SZ, Yang TJ, van Triest B, Verheij M. APO866, a novel NAD+ depleting cytotoxic agent with radiosensitizing properties. Radiother Oncol. 2009;90(Suppl.3):S85;[abstract 199]
  18. Kariya S, Tokuhiro S, Akima R, Ue H, Tsuzuki A, Nishioka A, et al. Hydrogen peroxide enhances radiation-induced apoptosis in human breast cancer cells. Radiother Oncol. 2009;90(Suppl.3):S115;[abstract 257]
  19. Ogawa Y, Kobayashi T, Kariya S, Nishioka A, Nakayama K, Seguchi H, et al. Prevention of hydrogen-induced apoptosis of human peripheral T cells by a lysomotropic iron chelator, ammonium chloride. Int J Mol Med. 2004;14:397–403
  20. Ogawa Y, Kubota K, Ue H, Kataoka Y, Miyatake K, Tadokoro M, et al. Phase I study of intra-tumoural injection of a newly developed enzyme-targeting radio-sensitizer (KORTUC) containing hydrogen peroxide and sodium hyaluronate for breast-conservation treatment without any surgical procedure. Radiother Oncol. 2009;90(Suppl.3):S73;[abstract 173]

PII: S0960-9776(09)00137-4

doi: 10.1016/j.breast.2009.10.008

The Breast
Volume 19, Issue 1 , Pages 23-27 , February 2010